跳至主要内容
临床试验/EUCTR2013-001096-20-IT
EUCTR2013-001096-20-IT进行中(未招募)不适用

ASSOCIATION BETWEEN PROTON-PUMP INHIBITORS (PPI) and METRONOMIC CAPECITABINE (mCAP) AS SALVAGE TREATMENT FOR PATIENTS WITH ADVANCED GASTRO-INTESTINAL TUMOURS: A RANDOMIZED PHASE II STUDY - metroCAP+PPI

Department of Molecular and Clinical Medicine; Sapienza University of Rome0 个研究点开始时间: 2014年1月31日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. pre-treated patients with advanced gastro-intestinal tumours 2. performance status (ECOG) =2
  • 3. life espectancy > 3 months
  • 4. adequate organ (liver, kidney, heart and bone marrow) function 5. patients must sign the consent form prior to registration
  • 6. patients must be accessible for treatment and follow up
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 33
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 33

排除标准

  • 1. Gastrointestinal tumours that can be treated with standard treatments
  • 2. Cardiovascular or CNS disease.
  • 3. Previously untreated CNS metastases.
  • 4. Pregnant or breast-feeding patients.
  • 5. Organ dysfunctions that usually hinder the use of cytotoxic drugs 6. Substance abuse and any other condition which may interfere with patient's participation in the study or evaluation of study results

研究者

发起方
Department of Molecular and Clinical Medicine; Sapienza University of Rome

相似试验